Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 75,622 | 0 | 0 | 0 | 0 |
| Gross Profit | 75,622 | N/A | N/A | N/A | N/A |
| Operating Expenses | 156,734 | 143,311 | 112,384 | 72,882 | 28,010 |
| Operating Income | -81,112 | -143,311 | -112,384 | -72,882 | -28,010 |
| Other Income | 10,982 | 8,297 | 3,883 | -1,076 | -7,869 |
| Pre-tax Income | -70,130 | -135,014 | -108,501 | -73,958 | -35,879 |
| Income Tax | 2,570 | 338 | N/A | N/A | N/A |
| Net Income Continuous | -72,700 | -135,352 | -108,501 | -73,958 | -35,879 |
| Net Income | $-72,700 | $-135,352 | $-108,501 | $-73,958 | $-35,879 |
| EPS Basic Total Ops | -0.98 | -2.63 | -2.30 | -2.96 | -23.65 |
| EPS Basic Continuous Ops | -0.98 | -2.63 | -2.30 | -2.96 | -23.65 |
| EPS Diluted Total Ops | -0.98 | -2.63 | -2.30 | -2.96 | -23.65 |
| EPS Diluted Continuous Ops | -0.98 | -2.63 | -2.30 | -2.96 | -23.65 |
| EPS Diluted Before Non-Recurring Items | -0.98 | -2.63 | -2.30 | -2.96 | N/A |
| EBITDA(a) | $-72,991 | $-137,089 | $-108,639 | $-70,750 | $-27,473 |